Has John Lockard, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,303 in general payments to John Lockard, MD across 65 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Lockard, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Lockard, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Lockard, MD

Pain Medicine · Sayre, PANPI 1811960560

Payments from drug & device makers

$2,303in general payments, 2019–2025

Across 65 payments — averaging $35.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$1K
SPR Therapeutics, Inc$351
Medtronic$307
Si-bone, Inc.$294
Boston Scientific$202
Biotronik NRO, Inc.$36

What the payments were for

Food & beverage$2,303100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	27	$1,113
SPR Therapeutics, Inc	10	$351
Medtronic(2 entities)	11	$307
Si-bone, Inc.	7	$294
Boston Scientific	8	$202
Biotronik NRO, Inc.	2	$36

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,303 in reported general payments places this provider in the 55th percentile of 294 pain medicine providers in Pennsylvania.

See all pain medicine providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$102,880

Medicare patients

381

Services billed

1,089

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MovantikNaloxegol Oxalate	12	$4,623
Baclofen	15	$294
Pregabalin	19	$247
Oxycodone Hcl	14	$226
Tizanidine Hcl	16	$201
Gabapentin	12	$165
Tramadol Hcl	12	$130
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	17	$128
Cephalexin	12	$80

Paid to pharmacies, not to this prescriber.

Other pain medicine in Sayre

Daniel GruenerPhiladelphia$2.9M
Peter PryzbylkowskiPhiladelphia$508K
Yeshvant NavalgundGreensburg$388K
Jack SmithWilliamsport$324K
Sanjay GuptaBala Cynwyd$241K
Vwaire OrhurhuWilliamsport$191K
Philip KimBryn Mawr$178K
Farooq QureshiQuakertown$130K
Matthew DrakeleyCoraopolis$99K
Bruce NicholsonAllentown$85K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →